|Usage:||Professional Use||Shelf Life:||24 Months|
FDA Morphine Rapid Test Kit,
MOP300 Rapid Test Kit,
MOP300 Rapid Test Cassette
Morphine (MOP300) Rapid Test Kit Drug of Abuse Rapid Test Cassette for Urine Sample
Morphine (MOP300) Rapid Test is a rapid, screening test for the qualitative detection ofMorphine and metabolites in human urine at specified cut oflevels.
For professional use only.
For in vitro diagnostic use only.
Morphine (MOP300) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Morphine (MOP300) listed in the table below.
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to Morphine (MOP300) of abuse test result, particularly when preliminary positive results are indicated.
Opiates refer to any drug that is derived from the opium poppy, including the natural products, morphine and codeine, and the semi-synthetic drugs such as heroin. Opiates exert their effects on the central nervous system and organs containing smooth muscle. Opiates manifest their presence by analgesia, drowsiness, euphoria, lowering of body temperature, respiratory depression, blockade of adrenocortical response. The major pathways of elimination are kidneys (urine) and the liver where it is conjugated to glucuronic acid. Opiates and their metabolites can be detected in urine as result of heroin, morphine, codeine or poppy seed intake. One Step Multi-drug Test Cup yields a positive result when the concentration of Opiates in urine exceeds 300ng/mL.
Morphine (MOP300) Rapid Test is a competitive immunoassay that is used to screen for the presence of Morphine (MOP300) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the Test , which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region,
indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of Test , if the test has been performed properly.
【WARNINGS AND PRECAUTIONS】
【STORAGE AND STABILITY】
【INTERPRETATION OF RESULTS】
Preliminary positive (+)
Only one colored band appears, in the control region (C). No colored band appears in the test region (T).
Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.